472 related articles for article (PubMed ID: 21138628)
21. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
[TBL] [Abstract][Full Text] [Related]
22. Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.
Margeridon S; Carrouée-Durantel S; Chemin I; Barraud L; Zoulim F; Trépo C; Kay A
Antimicrob Agents Chemother; 2008 Sep; 52(9):3068-73. PubMed ID: 18606836
[TBL] [Abstract][Full Text] [Related]
23. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
Ogata N; Ichida T; Aoyagi Y; Kitajima I
Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252
[TBL] [Abstract][Full Text] [Related]
24. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
Lin LY; Wong VW; Zhou HJ; Chan HY; Gui HL; Guo SM; Wang H; Huang L; Bao SS; Xie Q; Chan HL
J Med Virol; 2010 Sep; 82(9):1494-500. PubMed ID: 20648602
[TBL] [Abstract][Full Text] [Related]
25. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.
Kim JW; Lee SH; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH
Intervirology; 2011; 54(6):316-25. PubMed ID: 21242658
[TBL] [Abstract][Full Text] [Related]
26. PCR mediated recombination impacts the analysis of hepatitis B Virus covalently closed circular DNA.
Suspène R; Thiers V; Vartanian JP; Wain-Hobson S
Retrovirology; 2016 Dec; 13(1):84. PubMed ID: 27998270
[TBL] [Abstract][Full Text] [Related]
27. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
28. [Multiple-site analysis of HBV drug-resistant mutations in 340 patients with chronic hepatitis B].
Xu DP; Liu Y; Cheng J; Li XD; Dai JZ; Li L; Liang ZL; Bai L; Zhong YW; Xu ZH; Ren XQ; Zhang LX
Zhonghua Gan Zang Bing Za Zhi; 2008 Oct; 16(10):735-8. PubMed ID: 18983768
[TBL] [Abstract][Full Text] [Related]
29. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
30. [On the detection of HBV cccDNA and its clinical significance: an overview of research advancement].
Li H; Tang H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Jun; 26(3):662-6. PubMed ID: 19634693
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of transcriptional efficiency of hepatitis B virus covalently closed circular DNA by reverse transcription-PCR combined with the restriction enzyme digestion method.
Chou YC; Jeng KS; Chen ML; Liu HH; Liu TL; Chen YL; Liu YC; Hu CP; Chang C
J Virol; 2005 Feb; 79(3):1813-23. PubMed ID: 15650205
[TBL] [Abstract][Full Text] [Related]
32. [Dynamic expression of hepatitis B virus covalently closed circular DNA in 2.2.15 cell].
Liu MC; Wang GQ; Piao WH; Xi HL; Lu HY; Wang Y; Wang QH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):391-4. PubMed ID: 16416003
[TBL] [Abstract][Full Text] [Related]
33. Differences in sequences between HBV-relaxed circular DNA and covalently closed circular DNA.
Rybicka M; Woziwodzka A; Romanowski T; Stalke P; Dręczewski M; Bielawski KP
Emerg Microbes Infect; 2017 Jun; 6(6):e55. PubMed ID: 28634352
[TBL] [Abstract][Full Text] [Related]
34. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ
J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
[TBL] [Abstract][Full Text] [Related]
35. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas13-assisted hepatitis B virus covalently closed circular DNA detection.
Zhang X; Tian Y; Xu L; Fan Z; Cao Y; Ma Y; Li H; Ren F
Hepatol Int; 2022 Apr; 16(2):306-315. PubMed ID: 35298777
[TBL] [Abstract][Full Text] [Related]
37. Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients.
Takkenberg RB; Zaaijer HL; Menting S; Weegink CJ; Terpstra V; Cornelissen M; Dijkgraaf MG; Jansen PL; Reesink HW; Beld MG
Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):952-60. PubMed ID: 20150816
[TBL] [Abstract][Full Text] [Related]
38. [Mutation patterns in the RT region of hepatitis B virus P gene in patients treated with nucleoside/nucleotide analogs].
DENG J; ZHANG DH; YU DM; CHEN L; ZHANG XX
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):342-5. PubMed ID: 19497198
[TBL] [Abstract][Full Text] [Related]
39. [A quantitative real time polymerase chain reaction for detection of HBV covalently closed circular DNA in livers of the HBV infected patients].
Wang MR; Qiu N; Lu SC; Xiu DR; Yu JG; Li T; Liu XE; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):504-9. PubMed ID: 21569737
[TBL] [Abstract][Full Text] [Related]
40. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
